BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38059681)

  • 21. The effect of narrowband ultraviolet B phototherapy on serum folate level.
    Shirzadian Kebria A; Hosseini M; Khafri S
    Caspian J Intern Med; 2021 Mar; 12(2):180-183. PubMed ID: 34012536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of phototherapy in geriatric patients: a retrospective study.
    Bulur I; Erdogan HK; Aksu AE; Karapınar T; Saracoglu ZN
    An Bras Dermatol; 2018; 93(1):33-38. PubMed ID: 29641694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides.
    Lokitz ML; Wong HK
    Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):255-7. PubMed ID: 17986063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Narrowband UVB phototherapy in skin conditions beyond psoriasis.
    Gambichler T; Breuckmann F; Boms S; Altmeyer P; Kreuter A
    J Am Acad Dermatol; 2005 Apr; 52(4):660-70. PubMed ID: 15793518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
    Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
    Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Narrowband UVB phototherapy for early-stage mycosis fungoides.
    Gathers RC; Scherschun L; Malick F; Fivenson DP; Lim HW
    J Am Acad Dermatol; 2002 Aug; 47(2):191-7. PubMed ID: 12140464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses.
    Samson Yashar S; Gielczyk R; Scherschun L; Lim HW
    Photodermatol Photoimmunol Photomed; 2003 Aug; 19(4):164-8. PubMed ID: 12925186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phototherapy for mycosis fungoides.
    Dogra S; Mahajan R
    Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
    Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo.
    Pacifico A; Damiani G; Iacovelli P; Conic RRZ; ; Gonzalez S; Morrone A
    Dermatol Ther; 2021 Mar; 34(2):e14776. PubMed ID: 33433041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB-UVB therapy when exposed to sunlight.
    McCoy J; Goren A; Lotti T
    Dermatol Ther; 2014; 27(2):117-20. PubMed ID: 23952638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined therapy of psoralen plus ultraviolet A followed by narrow band ultraviolet B photochemotherapy for early stage mycosis fungoides].
    Wang T; Liu Y; Zheng H; Zuo Y; Fang K
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):626-8. PubMed ID: 25430032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultraviolet phototherapy for cutaneous diseases: a concise review.
    Vangipuram R; Feldman SR
    Oral Dis; 2016 May; 22(4):253-9. PubMed ID: 26464123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate did not add skin cancer risk in patients with psoriasis receiving narrowband ultraviolet B phototherapy: a nationwide retrospective cohort study.
    Chao CH; Wu CY; Chou FL; Chen YJ
    Clin Exp Dermatol; 2024 Apr; 49(5):459-465. PubMed ID: 38056487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phototherapy in the age of biologics.
    Walker D; Jacobe H
    Semin Cutan Med Surg; 2011 Dec; 30(4):190-8. PubMed ID: 22123416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.